Coronavirus Watch: Another vaccine candidate shows promise
AstraZeneca announced Monday that trials show its COVID-19 vaccine candidate is up to 90% effective in preventing disease, and its relatively simple distribution process could make it easier for people in developing countries to receive it.
That makes three vaccines – one each from Pfizer, Moderna and now AstraZeneca – that are showing promise for widespread effectiveness. Here's what we know about them.
It's Monday and this is Coronavirus Watch from the Paste BN Network. Here are today's headlines, as of 1:30 p.m. EST.
- Sunday was the busiest day at U.S. airport security checkpoints since March – evidence that Americans are still traveling for Thanksgiving despite CDC recommendations.
- Financial safety nets could soon be disappearing if Congress doesn't break a monthslong impasse. Analysts expect most or all relief programs to be reinstated, but an interruption could still bring issues.
- Vaccine candidates being developed by Pfizer and Moderna feature a never-before-used technology that could transform how science fights diseases.
COVID-19 cases continue to come in droves and some states are tightening their restrictions. Here's where to keep up with the latest restrictions in your state.
As always, thank you for subscribing to the Coronavirus Watch newsletter. Know someone who could use daily news updates right in their inbox? They can sign up here.
– Jay Cannon, Paste BN Network and Wires Editor, @JayTCannon on Twitter